- Source: Methylenedioxyallylamphetamine
Methylenedioxyallylamphetamine (MDAL or 3,4-methylenedioxy-N-allylamphetamine) is a lesser-known psychedelic drug. It is also the N-allyl derivative of 3,4-methylenedioxyamphetamine (MDA). MDAL was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 180 mg, and the duration unknown. MDAL produces few to no effects on its own, but may enhance the effects of LSD. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDAL.
Legality
= United Kingdom
=This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.
See also
Benzofuranylpropylaminopentane
Phenylpropylaminopentane
Phenethylamine
MDPR